{"id":"https://openalex.org/W3029622210","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps5091","title":"A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) \u00b1 linrodostat mesylate, followed by adjuvant postsurgical NIVO \u00b1 linrodostat, in cisplatin-eligible muscle invasive bladder cancer (MIBC).","display_name":"A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) \u00b1 linrodostat mesylate, followed by adjuvant postsurgical NIVO \u00b1 linrodostat, in cisplatin-eligible muscle invasive bladder cancer (MIBC).","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3029622210","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps5091","mag":"3029622210"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.tps5091","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps5091","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps5091","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052069729","display_name":"Guru Sonpavde","orcid":"https://orcid.org/0000-0002-1010-9611","observed_orcids":["https://orcid.org/0000-0002-1010-9611"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guru Sonpavde","raw_affiliation_strings":["Department of Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083331837","display_name":"Andrea Necchi","orcid":"https://orcid.org/0000-0002-3007-2756","observed_orcids":["https://orcid.org/0000-0002-3007-2756"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Necchi","raw_affiliation_strings":["Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017229890","display_name":"Shilpa Gupta","orcid":"https://orcid.org/0000-0002-8775-503X","observed_orcids":["https://orcid.org/0000-0002-8775-503X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shilpa Gupta","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055374861","display_name":"Gary D. Steinberg","orcid":"https://orcid.org/0000-0003-4469-0624","observed_orcids":["https://orcid.org/0000-0003-4469-0624"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary D. Steinberg","raw_affiliation_strings":["NYU Langone Health, Perlmutter Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone Health, Perlmutter Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114034271","display_name":"Juergen E. Gschwend","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62916508","display_name":"Technical University of Munich","ror":"https://ror.org/02kkvpp62","country_code":"DE","type":"education","lineage":["https://openalex.org/I62916508"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Juergen Gschwend","raw_affiliation_strings":["Department of Urology, Technical University of Munich, Munich, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Technical University of Munich, Munich, Germany;","institution_ids":["https://openalex.org/I62916508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104031744","display_name":"Michiel Simon Van Der Heijden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Michiel Simon Van Der Heijden","raw_affiliation_strings":["Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026775183","display_name":"Audrey Richiero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Audrey Richiero","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021050557","display_name":"Alexandre Lambert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre Lambert","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059594381","display_name":"Bradley Raybold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Raybold","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025610895","display_name":"Srikanth Gajavelli","orcid":"https://orcid.org/0000-0003-4840-9094","observed_orcids":["https://orcid.org/0000-0003-4840-9094"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srikanth Gajavelli","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107832821","display_name":"Dimitrios Zardavas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dimitrios Zardavas","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018275141","display_name":"Matthew D. Galsky","orcid":"https://orcid.org/0000-0001-7655-9378","observed_orcids":["https://orcid.org/0000-0001-7655-9378"]},"institutions":[{"id":"https://openalex.org/I4390039328","display_name":"Tisch Cancer Institute","ror":"https://ror.org/0317dzj93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I4390039328","https://openalex.org/I98704320"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt D. Galsky","raw_affiliation_strings":["Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY;","institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"TPS5091","last_page":"TPS5091"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.013199999928474426,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/muscle-invasive-bladder-cancer","display_name":"muscle-invasive bladder cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9919999837875366},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/ido1-inhibitors","display_name":"IDO1 inhibitors","score":0.7689999938011169},{"id":"https://openalex.org/keywords/pd-1-pd-l1-axis","display_name":"PD-1/PD-L1 axis","score":0.7480000257492065},{"id":"https://openalex.org/keywords/radical-cystectomy","display_name":"radical cystectomy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/adjuvant-immunotherapy","display_name":"adjuvant immunotherapy","score":0.8930000066757202},{"id":"https://openalex.org/keywords/gemcitabine-cisplatin","display_name":"gemcitabine plus cisplatin","score":0.8169999718666077},{"id":"https://openalex.org/keywords/kynurenine","display_name":"kynurenine","score":0.6650000214576721},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.8090000152587891},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.6759999990463257},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.6610000133514404},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9262653589248657},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.7467948198318481},{"id":"https://openalex.org/C2775910329","wikidata":"https://www.wikidata.org/wiki/Q245995","display_name":"Cystectomy","level":4,"score":0.6885393857955933},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6626387238502502},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6465462446212769},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6238816380500793},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5195672512054443},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.515577495098114},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.501014232635498},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35494714975357056},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3506556749343872},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2904595732688904}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.tps5091","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps5091","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps5091","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332611","display_name":"Bristol-Myers Squibb Canada","ror":"https://ror.org/01r00g076"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2947916759","https://openalex.org/W2995899912","https://openalex.org/W3031108451","https://openalex.org/W4251612516","https://openalex.org/W3169728670","https://openalex.org/W2912011158","https://openalex.org/W4391333814","https://openalex.org/W4212998961","https://openalex.org/W3007839305","https://openalex.org/W2794076680"],"abstract_inverted_index":{"TPS5091":[0],"Background:":[1],"Immuno-oncology":[2],"(IO)":[3],"therapies":[4,60],"have":[5],"revolutionized":[6],"the":[7,25,81,85,180],"treatment":[8],"(tx)":[9],"of":[10,43,84,90,149,184,240,342],"pts":[11,18,44,138,198],"with":[12,19,56,67,106,134,139,199,208,238],"advanced":[13,107],"bladder":[14,101],"cancer":[15],"(advBC).":[16],"For":[17],"cisplatin-eligible,":[20],"muscle":[21],"invasive":[22],"BC":[23,69,77,97,254],"(MIBC),":[24],"recommended":[26],"tx":[27,196,307],"is":[28,65,94,104],"cisplatin-based":[29,230],"neoadjuvant":[30,306],"chemotherapy":[31],"(NAC)":[32],"prior":[33,147,247],"to":[34,52,74,124,265],"radical":[35],"cystectomy":[36],"(RC).":[37],"However,":[38],"since":[39],"only":[40],"\u2248":[41],"30%":[42],"achieve":[45],"a":[46,115,158,172,339],"pathologic":[47],"complete":[48],"response":[49],"(pCR)":[50],"translating":[51],"improved":[53],"long-term":[54],"outcomes":[55],"approved":[57],"regimens,":[58],"new":[59],"are":[61,227,258,321],"needed.":[62],"PD-L1":[63],"expression":[64,89],"associated":[66,105],"aggressive":[68],"and":[70,103,109,182,193,222,232,294,308,324,337],"has":[71,128,338],"been":[72],"shown":[73],"increase":[75],"in":[76,96,99,132,137,167,197,329,334],"after":[78,305],"NAC,":[79],"supporting":[80],"therapeutic":[82],"pursuit":[83],"PD-1/PD-L1":[86],"axis.":[87],"Additionally,":[88],"indoleamine":[91],"2,3-dioxygenase":[92],"(IDO)":[93],"higher":[95],"than":[98,256],"normal":[100],"tissue":[102],"disease":[108],"poor":[110],"clinical":[111,130],"outcome.":[112],"Linrodostat":[113],"mesylate,":[114],"selective,":[116],"potent,":[117],"once-daily":[118],"oral":[119,275],"IDO1":[120],"inhibitor":[121],"that":[122],"works":[123],"reduce":[125],"kynurenine":[126],"production,":[127],"demonstrated":[129],"activity":[131],"combination":[133],"NIVO":[135,164,187,273,282],"(anti\u2013PD-1)":[136],"IO":[140,195,299],"tx\u2013naive":[141],"advBC":[142],"who":[143,226],"had":[144],"\u2265":[145,205,219],"1":[146],"line":[148],"therapy":[150],"(ORR,":[151],"37%).":[152],"Taken":[153],"together,":[154],"these":[155],"data":[156],"provide":[157],"rationale":[159],"for":[160,229,253],"investigating":[161],"NAC":[162,185,231,267,271,280],"+":[163,165,272,274,281,283],"linrodostat":[166,189,284],"MIBC.":[168],"Here":[169],"we":[170],"describe":[171],"randomized,":[173],"partially":[174],"blinded,":[175],"phase":[176],"3":[177],"study":[178,328],"evaluating":[179],"efficacy":[181],"safety":[183],"\u00b1":[186,188],"followed":[190,287],"by":[191,288],"RC":[192,233,289],"continued":[194,298],"MIBC":[200,211],"(NCT03661320).":[201],"Methods:":[202],"Pts":[203,237,261],"aged":[204],"18":[206],"years":[207],"previously":[209],"untreated":[210],"(clinical":[212],"stage":[213],"T2-T4a,":[214],"N0,":[215],"M0),":[216],"creatinine":[217],"clearance":[218],"50":[220],"mL/min,":[221],"predominant":[223],"UC":[224],"histology":[225],"eligible":[228],"will":[234,262,296],"be":[235,263],"enrolled.":[236],"evidence":[239],"positive":[241],"lymph":[242],"node;":[243],"metastatic":[244],"BC;":[245],"or":[246,251,279],"systemic":[248],"therapy,":[249],"radiotherapy,":[250],"surgery":[252],"other":[255],"TURBT":[257],"not":[259],"eligible.":[260],"randomized":[264],"receive":[266,297],"(gemcitabine/cisplatin;":[268],"arm":[269],"A),":[270],"placebo":[276],"(arm":[277,285],"B),":[278],"C)":[286],"(all":[290],"arms);":[291],"arms":[292,315],"B":[293,316],"C":[295,312],"tx.":[300],"Primary":[301],"endpoints":[302,320],"include":[303],"pCR":[304],"event-free":[309],"survival":[310,323],"(arms":[311],"vs":[313,317],"A;":[314],"A).":[318],"Secondary":[319],"overall":[322],"safety.":[325],"This":[326],"global":[327],"28":[330],"countries":[331],"began":[332],"accrual":[333],"Nov":[335],"2018":[336],"target":[340],"enrollment":[341],"1200":[343],"pts.":[344],"Clinical":[345],"trial":[346],"information:":[347],"NCT03661320":[348],".":[349]},"counts_by_year":[{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-06-05T00:00:00"}